Eagle Pharmaceuticals Total Liabilities 2013-2023 | EGRX

Eagle Pharmaceuticals total liabilities from 2013 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.

Eagle Pharmaceuticals Total Liabilities 2013-2023 | EGRX

Eagle Pharmaceuticals total liabilities from 2013 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$196.7B
Stryker (SYK)$142.8B
Boston Scientific (BSX)$132.8B
EssilorLuxottica (ESLOY)$110.9B
Medtronic (MDT)$105.8B
Haleon (HLN)$44.2B
Lonza Group Ag (LZAGY)$43.1B
GE HealthCare Technologies (GEHC)$37.1B
ResMed (RMD)$35B
Terumo (TRUMY)$29.6B
Koninklijke Philips (PHG)$24.2B
Zimmer Biomet Holdings (ZBH)$21.2B
Insulet (PODD)$18.9B
Baxter (BAX)$15.5B
Smith & Nephew SNATS (SNN)$11.2B
BellRing Brands (BRBR)$10B
Bio-Rad Laboratories (BIO)$9.4B
Demant (WILYY)$8.3B
Lantheus Holdings (LNTH)$6.5B
Haemonetics (HAE)$4.1B
Prestige Consumer Healthcare (PBH)$4.1B
ICU Medical (ICUI)$4B
Perrigo (PRGO)$3.7B
Envista Holdings (NVST)$3.4B
Shandong Weigao Medical Polymer (SHWGF)$3B
GN Store Nord (GNNDY)$2.9B
QuidelOrtho (QDEL)$2.8B
Neogen (NEOG)$2.6B
LeMaitre Vascular (LMAT)$2.3B
Green Thumb Industries (GTBIF)$1.7B